Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Levomethamphetamine (INN: levmetamfetamine) is an optical isomer of methamphetamine primarily used as a topical nasal decongestant. Levomethamphetamine is used to treat nasal congestion from allergies and the common cold. It was first used medically as decongestant beginning in 1958 and has been used for such purposes, primarily in the United States…
History, Community, Culture & Measurement
Explore the main themes, entities and connections around Levomethamphetamine. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
dextromethamphetamine methamphetamine effects drug levoamphetamine nasal used decongestant mg doses oral potent racemic 10 less elimination subjective cyp2d6 urine 15
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Levomethamphetamine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Levomethamphetamine | Bioavailability | Oral: ~100% | 1.00 | infobox |
| Levomethamphetamine | CAS Number | 33817-09-3 Y | 1.00 | infobox |
| Levomethamphetamine | ChemSpider | 33634 Y | 1.00 | infobox |
| Levomethamphetamine | Chirality | Levorotatory enantiomer | 1.00 | infobox |
| Levomethamphetamine | CompTox Dashboard (EPA) | DTXSID30187474 | 1.00 | infobox |
| Levomethamphetamine | Drug class | Norepinephrine releasing agent; Decongestant | 1.00 | infobox |
| Levomethamphetamine | DrugBank | DB09571 | 1.00 | infobox |
| Levomethamphetamine | ECHA InfoCard | 100.046.974 | 1.00 | infobox |
| Levomethamphetamine | Elimination half-life | 10–15 hours | 1.00 | infobox |
| Levomethamphetamine | Excretion | Urine (41–49% unchanged, 2–3% as levoamphetamine) | 1.00 | infobox |
| Levomethamphetamine | Formula | C10H15N | 1.00 | infobox |
| Levomethamphetamine | KEGG | D02291 Y | 1.00 | infobox |
| Levomethamphetamine | Legal status | AU: S8 (Controlled drug) | 1.00 | infobox |
| Levomethamphetamine | Legal status | BR: Class F2 (Prohibited psychotropics) | 1.00 | infobox |
| Levomethamphetamine | Legal status | CA: Schedule I | 1.00 | infobox |
| Levomethamphetamine | Legal status | DE: Anlage II (Authorized trade only, not prescriptible) | 1.00 | infobox |
| Levomethamphetamine | Legal status | UK: Class A | 1.00 | infobox |
| Levomethamphetamine | Legal status | US: Schedule II and for specific formulations OTC | 1.00 | infobox |
| Levomethamphetamine | Legal status | UN: Psychotropic Schedule II | 1.00 | infobox |
| Levomethamphetamine | Legal status | SE: Förteckning I | 1.00 | infobox |
| Levomethamphetamine | Metabolism | Liver (CYP2D6) | 1.00 | infobox |
| Levomethamphetamine | Metabolites | Levoamphetamine | 1.00 | infobox |
| Levomethamphetamine | Molar mass | 149.237 g·mol−1 | 1.00 | infobox |
| Levomethamphetamine | Other names | l-methamphetamine; (-)-methamphetamine; (R)-methamphetamine; (R)-(-)-methamphetamine; l-desoxyephedrine; levodesoxyephedrine | 1.00 | infobox |
| Levomethamphetamine | PubChem CID | 36604 | 1.00 | infobox |
| Levomethamphetamine | Routes of administration | Medical: Intranasal Recreational: By mouth, intravenous, insufflation, inhalation, suppository | 1.00 | infobox |
| Levomethamphetamine | Trade names | Vicks VapoInhaler, others | 1.00 | infobox |
| Levomethamphetamine | UNII | Y24T9BT2Q2 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.